Login to Your Account



Financings Roundup


Monday, December 3, 2012
• Progenics Pharmaceuticals Inc., of Tarrytown, N.Y., priced its underwritten offering of 11 million shares at $2 per share, for gross proceeds of $22 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription